Ohio biotech industry celebrates state incentives left intact

Ohio flagCOLUMBUS, Ohio — While health-care providers were suffering, economic development officials in the medical industry said Ohio’s budget positioned them to take advantage of other states’ cutbacks.

Ohio left the Technology Investment Tax Credit, Ohio Venture Capital Fund and Innovation Ohio Loan Fund intact. Advocates who work with those projects said they can leverage economic problems nationally to draw in more business, maximize funding and lure venture investors into the state they may not have otherwise.

“As I look at my colleagues’ programs across the country — Massachusetts, New York and even Pennsylvania — their investments in technology and economic growth have faced a significant reduction,” said Baiju Shah, president of BioEnterprise. “That’s a real opportunity for Ohio and in an environment we’re continuing state investing in its future.”

The dynamics of private equity have changed in the past year, however. Industry experts predict many venture firms will either fold or significantly contract, and venture investing is down.Venture capital investing has dropped to its lowest levels since 2003 and private-equity fund-raising in the first half of 2009 is down by more than two-thirds, according to Dow Jones Private Equity Analyst.

However, early-stage investing — the wheelhouse for most of the state’s life science sector — has grown in Ohio. A study released this month (pdf) by Ohio State University said seed and early-stage venture investing were up 50 percent in 2008. Nationally, such investments had dropped 20 percent.

In addition, health-care funds continue to raise money. Midwest-based Venture Investors recently announced its plans to raise a new fund, and other new funds include Excel Venture Management; 5AM Ventures; ABS Capital Partners and Blood Sweat & Capital; as well as Essex Woodlands and Google Health.

The pipeline of venture funds coming to Ohio “is growing because of the national trends,” said Paul Cohn, vice president and regional director of The Ohio Capital Fund. “Because it’s so difficult for the funds themselves we have more funds coming to us and willing to open up an Ohio office if we consider investing in them.”

Reblog this post [with Zemanta]
Chris Seper

Chris Seper MedCity News

Chris Seper is the CEO and editor in chief at MedCity Media, which publishes MedCityNews.com. Reach him at chris@medcitynews.com.

more

Comments RSS Post a comment

[...] see at least a continuation of the status quo, in terms of Medicaid money through the state. And economic development organizations were heartened Tuesday by the preservation of state technology investment [...]

Comment by Ohio’s two-year budget could devastate some community health services; cost jobs, businesses : MedCity News — July 14, 2009 @ 5:04 pm

[...] the state’s life-science industry can capitalize on the budget’s perceived positives: keeping critical economic incentives even as other states cut back on theirs and the venture capital industry [...]

Comment by A final budget that no one believes is finished — MedCity Weekend Rounds, July 17 : MedCity News — July 17, 2009 @ 10:47 pm

[...] gains. It’s a tough time for the VC industry: Venture capital investing has dropped to its lowest levels since 2003 and private-equity fund-raising in the first half of 2009 was down by more than [...]

Comment by The end of VC tax breaks? Don’t bet on it: MedCity Morning Read, Dec. 16, 2009 : MedCity News — December 16, 2009 @ 9:38 am

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics